NOA rizatriptan (as benzoate) 10 mg orodispersible tablet blister pack

国: オーストラリア

言語: 英語

ソース: Department of Health (Therapeutic Goods Administration)

即購入

公開評価報告書 公開評価報告書 (PAR)
26-11-2017

有効成分:

rizatriptan benzoate, Quantity: 14.53 mg (Equivalent: rizatriptan, Qty 10 mg)

から入手可能:

Medis Pharma Pty Ltd

INN(国際名):

rizatriptan benzoate

医薬品形態:

Tablet, orally disintegrating

構図:

Excipient Ingredients: crospovidone; calcium silicate; aspartame; microcrystalline cellulose; colloidal anhydrous silica; magnesium stearate; mannitol; Flavour

投与経路:

Oral

パッケージ内のユニット:

3, 6, 2

処方タイプ:

(S4) Prescription Only Medicine

適応症:

NOA is indicated for the acute treatment of migraine attacks with or without aura.

製品概要:

Visual Identification: White, round, flat, bevel-edged tablet embossed with "IZ 10" on one side and plain on the other side; Container Type: Blister Pack; Container Material: PA/Al/PVC/Al - polyamide-aluminium foil-polyvinylchloride/aluminium foil; Container Life Time: 36 Months; Container Temperature: Store below 30 degrees Celsius

認証ステータス:

Licence status A

承認日:

2015-02-19